ScRNAseq of BRAF-mutant Colo205 cells control or treated for 24h or 72h with vemurafenib
Ontology highlight
ABSTRACT: The experiment investigates transcriptional response of BRAF-mut Colo205 cancer cells following treatment for 24h or 72h with BRAF-inhibitor vemurafenib compared to control cells on a single cell level.
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Homo sapiens
SUBMITTER: Johannes Braegelmann
PROVIDER: E-MTAB-9890 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA